The patient was a 35-year-old woman with no personal history.
On January 21, 2020 he traveled to Japan from Wuhan (China).
He was healthy until January 30, when he had fever and mild diarrhea.
On January 31, in the primary care clinic, a rapid test of influenza antigens was performed and it was negative.
A chest CT scan revealed signs of pneumonia in the lower left lung area and was sent to the Red Cross Hospital Japonesa de Narita.
She reported no throat irritation, rhinorrhea, chills, or cough.
He had not come to the Huanan market, and had not been exposed to wild or dead animals.
On admission, her vital signs were: blood pressure 106/66 mmHG, pulse 93 l.p.m., temperature 37.9 Â°C, respiratory rate 16 r.p.m.
and oxygen saturation in ambient air 97%.
Physical examination was normal.
Laboratory tests showed no leukocytosis, leucocyte or high levels of liver enzymes.
A chest CT scan showed mild ground glass opacities in the lower lobe of the left lung.
Seated to a negative pressure isolation room.
Ceftriaxone was administered and the pharyngeal swab was obtained.
PCR of the pharyngeal smear for the new coronavirus (SARS-CoV-2) was negative.
He continued with fever but did not present respiratory symptoms, such as cough.
On day 5 of hospitalization, induced sputum and a second pharyngeal smear were obtained.
Sputum PCR test was positive, but pharyngeal smear was negative.
Her condition was stable and fever and diarrhea improved on the sixth day of hospitalization.
On the 12th day of hospitalization, the patient had already completely recovered and the sputum PCR and pharyngeal smear tests were negative.
During the entire clinical course, no positive test of pharyngeal swabs was obtained by PCR.
All PCR assays were performed in the reference laboratory by real-time RT-PCR assays following a previously described protocol.
